Date of Defense


Date of Graduation



Chemical and Paper Engineering

First Advisor

James Springstead

Second Advisor

Mert Atilhan


The objective of this project is to design a process to produce an mRNA influenza vaccine that serves as an alternative to conventional influenza vaccines, replacing current options with innovative mRNA technologies. Given that older populations are most likely to follow up on immunizations consistently, and the increasing average age worldwide, the market for this project appears to be expanding in the next 80 years. Additionally, experts predict more frequent mutations and outbreaks of viral disease from a variety of factors including globalization and global temperature trends. Rapid response to these viral outbreaks will continue to be as, or even more important than with COVID-19. To meet this anticipated demand, this group will design a plant to produce this updated vaccine and complete an economic analysis to determine a target price that will have to be met to satisfy adequate return on investment.


Co-authored with:

Ivan Corcuera Loya

Adam Alassa

Abdulohab Aldhfeeri

Access Setting

Honors Thesis-Open Access

Senior Design Slide Show.pdf (1708 kB)
Defense Presentation